Clinical verification of Cucurbitapepo: A multicentric prospectiveinterventional single arm clinical trial

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1. Participants presenting with minimum of three signs and symptoms corresponding to the signs and symptoms attributed to the medicines to be verified.
•2. Participants presenting with acute or chronic clinical conditions as per the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.
•3. Participants who are not taking any homoeopathic medication for their acute presenting complaints.
•4. Participants who have not taken any homoeopathic medication for the past one week for their chronic complaints or those agreeing for a washout period of one week for discontinuing ongoing medications.
•5. Participants willing to participate in the study and giving the written informed consent/ assent.

•1. Participants presenting with the clinical presentations other than the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.
•2. Participants with history of uncontrolled or life-threatening disease/ systemic illness (tuberculosis, cancer, AIDS, diabetes, hypertension, cardiovascular disorders etc.).
•3. Any pre-existing psychiatric disorder.
•4. Participants taking concomitant medications like immuno-suppressants, hormonal therapies or other Ayush therapies/ herbal medicines etc. for chronic ailments.
•5. Substance abuse and/or dependence.
•6. Pregnant and lactating women.
•7. Participants deemed unfit by investigator.
•8. Participants not willing to give the written informed consent/ assent.

发起方

Central Council for Research in Homoeopathy